A randomized study of the safety and pharmacokinetics of GSK3358699, a mononuclear myeloid-targeted bromodomain and extra-terminal domain inhibitor
一项关于GSK3358699(一种单核髓系靶向溴结构域和末端外结构域抑制剂)的安全性和药代动力学的随机研究
期刊:British Journal of Clinical Pharmacology
影响因子:3
doi:10.1111/bcp.15137
Brown, Jack A; Bal, Joanne; Simeoni, Monica; Williams, Peter; Mander, Palwinder K; Soden, Peter E; Daga, Shruti; Fahy, William A; Wong, Gabriel K; Bloomer, Jackie C; Erwig, Lars; Cui, Yi; Fernando, Disala; Carnaghan, Helen; Banham-Hall, Edward J; Hopkins, Sarah; Davis, Bill G; Oliveira, Joao J D; Prinjha, Rabinder K